Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac Diethylamine 2.32% Gel in Knee Osteoarthritis
NCT01967550Phase 3Completed
- Sponsor
- Novartis
- Start
- Oct 2013
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of diclofenac diethylammonium in osteoarthritis (OA) (2 arms), sponsored by Novartis. Primary endpoint: Pain On Movement at 2 weeks. Started Oct 2013; status: completed.
02
Drugs
diclofenac diethylammonium
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01967550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01967550.